These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15100671)

  • 1. Levocetirizine better protects than desloratadine in a nasal provocation with allergen.
    Deruaz C; Leimgruber A; Berney M; Pradervand E; Spertini F
    J Allergy Clin Immunol; 2004 Apr; 113(4):669-76. PubMed ID: 15100671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
    Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
    Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study.
    Yonekura S; Okamoto Y; Sakurai D; Iinuma T; Sakurai T; Yoneda R; Kurita J; Hanazawa T; Kawasaki Y
    Int Arch Allergy Immunol; 2019; 180(4):274-283. PubMed ID: 31618733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
    Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
    Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine.
    Frossard N; Strolin-Benedetti M; Purohit A; Pauli G
    Br J Clin Pharmacol; 2008 Feb; 65(2):172-9. PubMed ID: 17953719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
    Stübner P; Zieglmayer R; Horak F
    Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA
    Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients.
    Reinartz SM; Overbeek SE; Kleinjan A; van Drunen CM; Braunstahl GJ; Hoogsteden HC; Fokkens WJ
    Allergy; 2005 Oct; 60(10):1301-7. PubMed ID: 16134997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU).
    Day JH; Briscoe MP; Rafeiro E; Ratz JD
    Int J Clin Pract; 2004 Feb; 58(2):109-18. PubMed ID: 15055856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
    Kłos K; Kruszewski J; Kruszewski R; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
    Greiff L; Persson CG; Andersson M
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours.
    Passalacqua G; Guerra L; Compalati E; Massacane P; Rogkakou A; Zanella C; Baena-Cagnani R; Canonica GW
    Int Arch Allergy Immunol; 2004 Oct; 135(2):143-7. PubMed ID: 15345913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
    Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
    J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
    Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ
    Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel antihistamine SUN-1334H.
    Mandhane SN; Shah JH; Bahekar PC; Mehetre SV; Pawar CA; Bagad AS; Chidrewar GU; Rao CT; Rajamannar T
    Int Arch Allergy Immunol; 2010; 151(1):56-69. PubMed ID: 19672097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
    Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J
    J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new antihistamines--desloratadine and levocetirizine: a review.
    Scheinfeld N
    J Drugs Dermatol; 2002 Dec; 1(3):311-6. PubMed ID: 12851991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.